| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/12/13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
41 |
| 05/02/13 | 8-K | Current report filing |
|
5 | |
| 03/22/13 | DEF 14A | Definitive proxy statements |
|
31 | |
| 03/13/13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
40 |
| 02/13/13 | 8-K | Current report filing |
|
5 | |
| 01/29/13 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
143 |
| 01/28/13 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
9 | |
| 11/23/12 | 8-K | Current report filing |
|
31 | |
| 10/15/12 | 8-K | Current report filing |
|
5 | |
| 10/11/12 | 8-K | Current report filing |
|
4 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.